Skip to main content
. 2021 Sep 21;13:7299–7309. doi: 10.2147/CMAR.S318378

Figure 1.

Figure 1

SNHG22 is upregulated in ovarian cancer. (A, B) the qRT-PCR analysis was used to evaluate SNHG22 expression in 60 paired tumor and paired adjacent non-tumor tissues. (C) The expression profiles of SNHG22 in ES-2, HO-8910, OVCAR-3, A2780 and human normal ovarian epithelial (HNOE) were detected with qRT-PCR. (D) The expression of SNHG22 in HNSC, KIRC, KIRP, LIHC, READ, STAD, THCA and UCEC. *P < 0.05, **P < 0.01, ***P < 0.001.